Athersys plans to sell $12 million in securities to raise cash for operations


The move comes amid financial and operational restructuring at the regenerative medicine company.

Previous Why is there a shortage of nurses in Massachusetts?
Next Popular Portland brewer expands restaurant portfolio with NE Portland eatery